Inventaire - your friends and communities are your best library

Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy

Published in: European Journal of Clinical Microbiology & Infectious Diseases

Date of publication: July 1, 2005

Main subject: gram-negative bacteria, antimicrobial resistance

Bibliographic databases:

Cites articles 32

Date

Title

Authors

November 1, 1983

Effect of Broad-Spectrum Cephalosporins on the Microbial Flora of Recipients
October 1, 1985

Influence of ceftriaxone on bacterial flora in human feces
January 1, 1986

Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy
August 1, 1987

Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery
April 1, 1992

Effect of a Broad-Spectrum Cephalosporin on the Oral and Intestinal Microflora in Patients Undergoing Colorectal Surgery
February 1, 1995

Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children
July 1, 1997

Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli,Antimicrobial Resistance with Focus on β-Lactam Resistance in Gram-Negative Bacilli
July 1, 1998

Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value?,Spread of Extended‐Spectrum β‐Lactamase–ProducingKlebsiella pneumoniae: Are β‐Lactamase Inhibitors of Therapeutic Value?
October 1, 1998

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
February 1, 1999

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
December 1, 2000

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients
March 1, 2000

Vancomycin-resistant enterococcal infections
September 14, 2001

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
June 1, 2001

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory
June 1, 2002

The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
July 1, 2002

Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals

,
January 1, 2002

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary
March 15, 2002

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms
January 25, 2002

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?
January 1, 2002

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

, ,
September 1, 2002

Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults
December 21, 2003

SOS response promotes horizontal dissemination of antibiotic resistance genes
February 1, 2003

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial
September 1, 2003

Ertapenem, the first of a new group of carbapenems
September 25, 2003

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections

, , , , , ,
April 17, 2003

The epidemiology of sepsis in the United States from 1979 through 2000

,
September 1, 2003

Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients,Antianaerobic Antibiotic Therapy Promotes Overgrowth of Antibiotic-Resistant, Gram-Negative Bacilli and Vancomycin-Resistant Enterococci in the Stool of Colonized Patients
November 1, 2003

Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases

,
February 1, 2003

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.
January 1, 2004

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections

, , , , , , , ,
June 25, 2004

The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens
May 1, 2004

"Collateral damage" from cephalosporin or quinolone antibiotic therapy

Article -

Welcome to inventaire

The library of your friends and communities

You are offline